NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00675012
Recruitment Status : Completed
First Posted : May 8, 2008
Last Update Posted : May 30, 2014
Information provided by (Responsible Party):
MolMed S.p.A.